511 related articles for article (PubMed ID: 24126372)
1. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
2. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
5. Breast MR imaging screening in women with a history of breast conservation therapy.
Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
8. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
9. Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
Millet I; Curros-Doyon F; Molinari N; Bouic-Pages E; Prat X; Alili C; Taourel P
Radiology; 2014 Jan; 270(1):57-66. PubMed ID: 24029641
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
Kim JJ; Kim JY; Kang HJ; Shin JK; Kang T; Lee SW; Bae YT
Radiology; 2017 Jul; 284(1):45-54. PubMed ID: 28253106
[TBL] [Abstract][Full Text] [Related]
12. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
13. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
[TBL] [Abstract][Full Text] [Related]
15. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ.
Tamura N; Tsuda H; Yoshida M; Hojo T; Akashi-Tanaka S; Kinoshita T; Sugihara K
Breast Cancer; 2016 May; 23(3):510-8. PubMed ID: 25666939
[TBL] [Abstract][Full Text] [Related]
17. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
Acta Radiol; 2016 Jul; 57(7):802-8. PubMed ID: 26516288
[TBL] [Abstract][Full Text] [Related]
18. Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
[TBL] [Abstract][Full Text] [Related]
19. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
20. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
Luo J; Johnston BS; Kitsch AE; Hippe DS; Korde LA; Javid S; Lee JM; Peacock S; Lehman CD; Partridge SC; Rahbar H
Radiology; 2017 Dec; 285(3):788-797. PubMed ID: 28914599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]